Neoadjuvant Chemotherapy in 16 Patients with Locally Advanced Papillary Thyroid Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neoadjuvant Chemotherapy in 16 Patients with Locally Advanced Papillary Thyroid Carcinoma

Published:2013-02 Issue:2 Volume:23 Page:178-184
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Besic Nikola¹,Auersperg Marija¹,Dremelj Marta²,Vidergar-Kralj Barbara³,Gazic Barbara⁴

Affiliation:

1. Department of Surgical Oncology, Institute of Oncology, Ljubljana, Slovenia.

2. Department of Radiotherapy, Institute of Oncology, Ljubljana, Slovenia.

3. Department of Nuclear Medicine, Institute of Oncology, Ljubljana, Slovenia.

4. Department of Pathology, Institute of Oncology, Ljubljana, Slovenia.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2012.0194

Reference27 articles.

1. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

2. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

3. Papillary and Follicular Thyroid Carcinoma

4. Ten-year follow-up of thyroid epidemiology in Slovenia after increase in salt iodization

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect and Safety of Apatinib as Neoadjuvant Therapy in Locally Advanced Differentiated Thyroid Cancer: A Phase 2 Trial;Journal of the Endocrine Society;2024-07-12

2. Neoadjuvant therapy prior to surgery for advanced thyroid cancer;Current Opinion in Endocrine and Metabolic Research;2023-10

3. Neoadjuvant Multikinase Inhibitor Therapy in Locally Advanced Unresectable Differentiated Thyroid Carcinoma: a Case Report;Indian Journal of Surgery;2022-12-14

4. Updated recommendations for the diagnosis and treatment of differentiated thyroid cancer;ONKOLOGIJA;2022

5. Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin;Biology;2022-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3